Archive | News Archive

Geisinger researchers find genetic abnormalities may cause cerebral palsy

DANVILLE, Pa – For years it was thought that a difficult birth and other perinatal factors were the leading causes of cerebral palsy (CP), a group of disorders that can involve brain and nervous system functions such as movement, learning, hearing, seeing and thinking. Now, researchers at Geisinger Health System find that the majority of cerebral palsy causes may in fact be caused by genetic abnormalities.

Published in the The Lancet Neurology, Geisinger researchers find that CP – the most common physical disability of childhood – is probably caused by multiple genetic factors, similar to other neurodevelopmental disorders such as autism and intellectual disability. The paper suggests physicians should consider performing genetic testing when children present with CP and CP-like conditions.

“There is a widespread misconception that most cases of CP are caused by difficult delivery leading to birth asphyxia,” said Andres Moreno De Luca, M.D., research scientist at the Genomic Medicine Institute, Geisinger Health System, and lead author of the paper. “What we’re finding is a growing body of evidence that suggests mutations in multiple genes are responsible for CP. In fact, we suspect these genetic abnormalities may also be the cause of some difficult births to begin with.”

Despite substantial improvements in obstetric and neonatal care, the paper finds the worldwide prevalence of cerebral palsy has remained stable at 2 to 3 per 1,000 livebirths for more than 40 years. Inadequate oxygen supply to fetuses, known as birth asphyxia, remains the most studied factor associated with CP, though electronic fetal monitoring and other technologies have been developed to detect fetal distress.

“What we’re finding is even though more preventative efforts have been put in place, like fetal monitoring, the incidence of CP has not decreased,” said David Ledbetter, Ph.D., chief scientific officer, Geisinger Health System. “We’ve seen a five-fold increase in the rate of caesarean sections, which are done in part to avoid potentially difficult delivery, and again, the CP rates remain steady. These findings lead us to believe genetics play a much bigger role than previously thought.”

The paper also reports that even though most cases of CP are not caused by birth asphyxia and those that are can rarely be prevented by obstetric intervention, between 1999 and 2003 an estimated 76 percent of obstetricians in the U.S. faced medical malpractice litigation, most often for alleged birth mismanagement resulting in CP.

“We now know of six genes that can cause CP when disrupted, and we estimate that many other developmental brain genes probably contribute to the genetic heterogeneity of this disorder,” said Dr. Moreno De Luca. “Many capable obstetricians face legal action even though research is telling us genetics is the likely cause of most cases of CP.”

As the paradigm shift continues and more researchers, clinicians, and the general population start to consider the cerebral palsies as a group of neurogenetic disorders, the paper states we will probably witness an increase in research efforts, a change in the diagnostic approach, and eventually novel therapies for treating CP.

About Geisinger Health System
Geisinger is an integrated health services organization widely recognized for its innovative use of the electronic health record, and the development and implementation of innovative care models including ProvenHealth Navigator, an advanced medical home model, and ProvenCare program. The system serves more than 2.6 million residents throughout 44 counties in central and northeastern Pennsylvania. For more information, visit  Geisinger. Follow the latest Geisinger news and more at Twitter and  Facebook.

Paper in The Lancet Neurology states intrapartum, postnatal conditions less of a factor

CONTACT: Che Parker: 570-271-7441
January 26, 2012
FOR IMMEDIATE RELEASE

 

Posted in News ArchiveComments (0)

New Fetal Oxygen Device

CHICAGO (WMAQ) – It’s small, but may have a huge impact by saving thousands of families the heartache of a baby born with cerebral palsy. It works by measuring the oxygen level of babies more accurately before birth. For every 100 babies born, one will be oxygen deprived. At its worst it can lead to crippling diseases like cerebral palsy. Right now doctors routinely monitor the fetal heartbeat and it gives some idea of the oxygen level, but not much. “It’s not extremely accurate,” said Dr. William Grobman. That can lead to unnecessary procedures like a c-section. So Dr. Bill Grobman is taking part in a nationwide study he hopes will lead to reducing the number of oxygen deprived babies by half. “This little end gets attached to the top of the baby’s head and this gets attached to the computer,” said Dr. Grobman. It’s a gold tip that can be inserted into the womb during labor. Preliminary European research shows it may measure oxygen levels so accurately that it can give a doctor a clear answer whether the baby needs to be delivered early. “It comes out with a large black box that indicates a greater chance of a problem with fetal oxygenation that needs to be attended to,” said Dr. Grobman. So far doctors at Northwestern have used the device on 65 women. But it may be several years before the study is completed.

Posted in News ArchiveComments (7)

A protein may help prevent brain damage that occurs in babies with CP

ADVANCE for Speech-Language Pathologists & Audiologists

 Cerebral Palsy

Posted on:January 18, 2012

Scientists at Washington University School of Medicine, in St. Louis, have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy [The Proceedings of the National Academy of Sciences,108 (47): 19054-59].Using a mouse model that mimics the condition in newborns, the researchers found that high levels of the protective protein Nmnat1 substantially reduce damage that develops when the brain is deprived of oxygen and blood flow. The finding offers a potential new strategy for treating cerebral palsy, stroke and perhaps Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

“Under normal circumstances the brain can handle a temporary disruption of either oxygen or blood flow during birth, but when they occur together and for long enough, long-term disability and death can result,” said senior author David Holtzman, MD, head of the Department of Neurology. “If we can use drugs to trigger the same protective pathway as Nmnat1, it may be possible to prevent brain damage that occurs from these conditions as well as from neurodegenerative diseases.”

The researchers are not sure how Nmnat1 protects brain cells, but they suspect it blocks the effects of the powerful neurotransmitter glutamate. Brain cells that are damaged or oxygen-starved release glutamate, which can overstimulate and kill neighboring nerve cells.

The protective effects of Nmnat1 first were identified five years ago by Jeff Milbrandt, MD, PhD, head of genetics, who showed the protein can prevent damage to peripheral nerves in the extremities of the body.

“Cerebral palsy is sometimes attributable to brain injury that stems from inadequate oxygen and blood flow to the brain before, during or soon after birth,” said first author Philip Verghese, PhD, a postdoctoral research associate. “We wanted to see if those injuries still occur in the presence of increased levels of Nmnat1.”

The researchers evaluated the effects of oxygen and blood flow deprivation in normal mice and in mice genetically engineered to produce higher-than-normal levels of Nmnat1. As early as six hours later, the mice with enhanced Nmnat1 had markedly less injury to the brain. A week later, when the researchers measured the amount of tissue atrophy in the brain, they found that mice with high Nmnat1 had experienced far less damage to key brain structures like the hippocampus and cortex, which are known to be injured in cerebral palsy.

In a series of follow-up studies with collaborators Jeff Neil, MD, PhD, and Yo Sasaki, PhD, the scientists were surprised to see that MRI brain scans showed Nmnat1 might be even more protective than the first experiment suggested. In mice with boosted Nmnat1 levels, the scans revealed little to no brain damage. Laboratory studies of the brain cells indicated that Nmnat1 prevents a particular form of cell death.

“There are two types of injury in the developing brain from inadequate oxygen and blood flow,” Dr. Holtzman explained. “One is necrosis, where cells swell rapidly, burst and die. Another is apoptosis, where the cells shrink and die. We found that Nmnat1 prevents necrosis.”

Necrosis is believed to be responsible for killing brain cells in ischemic stroke in adults. Dying cells flood the surrounding area with glutamate, which can harm nearby cells. When researchers simulated this process in a test tube, fewer brain cells died in the presence of high Nmnat1.

Scientists are following up on several potential explanations for the protective effects of Nmnat1. Dr. Holtzman plans to test the protein in other models of brain injuries and neurodegenerative diseases.

The research was supported by the National Institute of Neurological Disorders and Stroke and a grant from Mr. and Mrs. Mark Dehnert through the Goldman Sachs Gives fund.

Posted in News ArchiveComments (0)

Dr. Roberto Romero – CPI Research Foundation Advisors in the News

Dr. Roberto Romero – CPI Research Foundation Advisors in the News

Dr. Roberto Romero

Dr. Roberto Romero

Dr. Roberto Romero, Chief of the Perinatology Research Branch of the National Institute of Child Health and Development and a former member of the CPI Research Foundation Scientific Advisory Council (SAC), describes the importance of vaginal progesterone in reducing pre-term birth and neonatal complications in a recent press release from the Detroit Medical Center. For full article please click on the link below.

http://www.biospace.com/News/detroit-medical-center-release-major-new/243915/source=MoreNews

 

 

 

 

Posted in News ArchiveComments (0)

Dr. Diane Damiano – CPI Research Foundation Advisors in the News

Dr. Diane Damiano – CPI Research Foundation Advisors in the News

Dr. Diane Damiano

Dr. Diane Damiano

Dr. Diane Damiano, Chief of Functional and Applied Biomechanics Section at the NIH Clinical Center, longstanding member of the CPI Research Foundation SAC and one of our former Hausman awardees, was part of an NIH study team that tested the effectiveness of an electrical stimulator device (WalkAide) on individuals with CP that have a form of lower leg paralysis known as “foot drop”.

Please click on the link below for the full article.

http://www.marketwatch.com/story/nih-study-shows-walkaide-device-by-hanger-orthopedic-group-significantly-improves-walking-ability-in-children-with-cerebral-palsy-2011-12-12

Posted in News ArchiveComments (0)

Dance Therapy Paying Dividends

Dance Therapy Paying Dividends

Although Dr. Citlali Lopez-Ortiz’s research study through Northwestern University’s Rehabilitation Institute of Chicago has not yet been completed, Sophia Jablonski, an eleven year old with cerebral palsy who is participating in the Joffrey Ballet’s annual production of “The Nutcracker” is certainly helping make the case for this innovative form of therapy.

 

Dr. Lopez-Ortiz, recipient of a two year, $100,000 research grant from CPIRF made possible through the generosity of the Hearst Foundation, has been studying the effectiveness of canonical movements of classical ballet with accompanying music to improve movement and postured control in children between 10-12 years of age with hemiplegic or diplegic cerebral palsy.

 

Please click on the link below to read the recent press release from the Chicago Sun Times describing Sophia’s great progress!

 

http://www.suntimes.com/technology/innovation/entertainment/9465153-646/girl-with-cerebral-palsy-gets-shot-at-joffrey-nutcracker.html

Posted in News ArchiveComments (1)

CPI Research Foundation Board Approves $350,000 Funding for Four New Research Projects

CPI Research Foundation Board Approves $350,000 Funding for Four New Research Projects

The CPI Research Foundation board of directors met on October 26, 2011 and approved research funding for four new pilot studies (see below for further description). The grants, which were peer reviewed and recommended for funding to the board of directors by the CPI Research Foundation’s Scientific Advisory Council, represent a $200,000 commitment in 2012 and an anticipated additional $150,000 commitment in 2013. “With these research studies taking place in Washington D.C., San Francisco, Calgary, Canada and Victoria , Australia, there is both geographic and scientific diversity represented among these exciting new projects. Whether the path of scientific discovery is domestically and/or internationally based, our aim is to fund the best cerebral palsy research projects in the world” stated Glenn R. Tringali, CEO & President.

Posted in News ArchiveComments (0)

“Role of Astrocytes in Cerebral Palsy” Principal Investigator Vittorio Gallo, Ph.D., Children’s National Medical Center, Washington, DC

“Role of Astrocytes in Cerebral Palsy” Principal Investigator Vittorio Gallo, Ph.D., Children’s National Medical Center, Washington, DC

By gaining a better understanding of the role of altered astrocyte development and function in white matter brain injury after chronic hypoxia (HX), the study findings will help develop new cell-specific therapeutic approaches for brain injuries seen in premature infants with cerebral palsy and help to decrease neurological morbidity associated with cerebral palsy in very low birth weight infants (VLBW, <1500g).

Posted in News ArchiveComments (0)

“Maternal Pregnancy Complications and Risk of Cerebral Palsy: A Population Study” Principal Investigator Yvonne Wu, MD, MPH, University of California SF, San Francisco, CA

“Maternal Pregnancy Complications and Risk of Cerebral Palsy: A Population Study” Principal Investigator Yvonne Wu, MD, MPH, University of California SF, San Francisco, CA

By retrospectively comparing the data of 6 million California births during the years 1991 – 2001 with 8400 infants with CP within this birth cohort, this study will be among the first to focus primarily on pre-partum risk factors. The research is designed to uncover prenatal and pre-partum material characteristics important in the pathogenesis of CP, with the long term goal of developing new strategies and approaches to prevent CP.

Posted in News ArchiveComments (0)

“Preventing Undesired Side-Effects in the Treatment of Cerebral Palsy with Botox” Principal Investigator Dr. Walter Herzog, University of Calgary, Calgary, Canada

“Preventing Undesired Side-Effects in the Treatment of Cerebral Palsy with Botox” Principal Investigator Dr. Walter Herzog, University of Calgary, Calgary, Canada

Botulinum toxin type-A (BTXA) has been successfully used for treatment of cerebral palsy but has also demonstrated side effects that produce muscle atrophy, loss of strength, and loss of contractile material in target and non-target muscles. This study aims to examine if direct muscle stimulation training in conjunction with BTXA injections will reduce (possibly prevent) muscle atrophy, loss of strength and structural integrity in target and non-target muscles and vastly accelerate recovery of the target and non-target musculature to normal functional levels.

Posted in News ArchiveComments (3)

Most treatments for cerebral palsy (CP) are initially directed toward children. What is not clearly established is the long- term effects of such treatments. Many appear helpful in the short term but prove to be disadvantageous in the long run. Selective dorsal rhizotomy (SDR) is a permanent, irreversible neurosurgical procedure for reducing spasticity in cerebral palsy. Parents contemplating SDR for their child would like assurance that that there will not be harmful complications from it as the child ages into adolescence and adulthood. We now have new evidence... Continue reading this article.

new-cpirf-videos miracle-thumb

Why Paul Volcker Supports CP Research

miracle-thumb

Miracle in the Middle East

Electric_Stim_03

Electro-Stim


robotics_cpirf big

Robotics

CPIRF PSA

CPIRF PSA




Become a CPIRF Facebook Fan! And, encourage all of your friends to join! Our goal is to reach 10,000 fans. Once we reach our milestone, 10 fans, chosen at random, will receive a beautiful Live and Let Live bracelet designed by Catherine Zadeh!


YOU SEARCH OR SHOP
WE GIVE!
Search the Web now Money-saving coupons
Raise money for CPIRF just by searching the web and shopping online!